+Search query
-Structure paper
| Title | Mechanistic insights into the small-molecule inhibition of influenza A virus entry. |
|---|---|
| Journal, issue, pages | Proc Natl Acad Sci U S A, Vol. 122, Issue 33, Page e2503899122, Year 2025 |
| Publish date | Aug 19, 2025 |
Authors | Yan Xu / Varada Anirudhan / Irina N Gaisina / Haijuan Du / Saad Alqarni / Terry W Moore / Michael Caffrey / Balaji Manicassamy / Tongqing Zhou / Lijun Rong / Kai Xu / ![]() |
| PubMed Abstract | Influenza A virus (IAV) is a zoonotic pathogen responsible for seasonal and pandemic flu. The extensive genetic and antigenic diversity within and between IAV phylogenetic groups presents major ...Influenza A virus (IAV) is a zoonotic pathogen responsible for seasonal and pandemic flu. The extensive genetic and antigenic diversity within and between IAV phylogenetic groups presents major challenges for developing universal vaccines and broad-spectrum antiviral therapies. Current interventions provide limited protection due to the virus's high mutation rate and capacity for immune evasion. Recent advancements in viral hemagglutinin (HA)-targeting small-molecule entry inhibitors offer a promising avenue to overcome these limitations. Here, we present structural and functional analyses of two group 2 HA-specific small-molecule inhibitors recently identified by our team. Cryogenic electron microscopy (cryo-EM) structures revealed that these inhibitors bind a conserved pocket within the HA stalk, likely interfering with the conformational rearrangements necessary for membrane fusion and viral entry. Structure-guided mutagenesis confirmed the critical roles of key interacting residues and uncovered distinct resistance profiles between the two compounds, as well as in comparison to Arbidol, a previously reported HA inhibitor. Notably, our structural analysis highlights intrinsic barriers to achieving cross-group inhibition with current small-molecule designs. To address this, we propose an alternative strategy for broadening antiviral coverage. Together, these findings provide mechanistic insights into IAV entry inhibition and a foundation for the rational design of next-generation anti-influenza therapeutics. |
External links | Proc Natl Acad Sci U S A / PubMed:40802690 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2.76 - 2.77 Å |
| Structure data | EMDB-70657, PDB-9onz: EMDB-70658, PDB-9oo1: |
| Chemicals | ![]() ChemComp-NAG: ![]() PDB-1cc2: ![]() PDB-1cc3: |
| Source |
|
Keywords | VIRAL PROTEIN/INHIBITOR / Influenza A Virus / Hemagglutinin / Complex / Small-Molecule Inhibitor / Entry / SA-67 / VIRAL PROTEIN-INHIBITOR complex / ING-16-36 |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links







influenza a virus
Keywords